Novel prostate cancer resistance mechanism could be a promising target – Drug Target Review

Posted: 6 January 2021 | Hannah Balfour (Drug Target Review) | No comments yet
By inhibiting the activity of microRNA-194 (miR-194), scientists prevented prostate cancer cells from developing treatment resistance in vitro.
Researchers have identified a new mechanism through which prostate cancer cells convert to a more aggressive subtype in response to hormonal therapies. According to the team, further exploration of their findings may enable scientists to develop more targeted ways to remedy treatment…

Click here to view the original article.